Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Martinez

Showing results (361-370 of 463) with videos related to

Pageof 47
Sort By:
Cancer|March 5, 2020
Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastomaHamed Akbari, Saima Rathore, Spyridon Bakas, et al.
Journal of Medical Internet Research|November 14, 2022
The Codevelopment of "My Kidneys & Me": A Digital Self-management Program for People With Chronic Kidney DiseaseCourtney J Lightfoot, Thomas J Wilkinson, Michelle Hadjiconstantinou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid TumorsManuel Hidalgo, Maria Martinez-Garcia, Christophe Le Tourneau, et al.
Human Mutation|July 11, 2012
Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunitiesFlorian Mittag, Finja Büchel, Mohamad Saad, et al.
Scientific Reports|August 24, 2022
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastomaAinhoa Hernandez, Ana Maria Muñoz-Mármol, Anna Esteve-Codina, et al.
Archives of Neurology|February 11, 2009
Clinical and pathological continuum of multisystem TDP-43 proteinopathiesFelix Geser, Maria Martinez-Lage, John Robinson, et al.
Materials Science & Engineering. C, Materials for Biological Applications|March 4, 2017
Collagen-based silver nanoparticles: Study on cell viability, skin permeation, and swelling inhibitionVinicius Saura Cardoso, Marcelo de Carvalho Filgueiras, Yago Medeiros Dutra, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2023
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life settingAlba Rocabert, Beatriz Borjabad, Leire Berrocal, et al.
Journal of the National Cancer Institute|August 18, 2016
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled TrialPatricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutationsLisa Zimmer, Fabrice Barlesi, Maria Martinez-Garcia, et al.
Pageof 47

Showing results (361-370 of 463) with videos related to

Sort By:
Pageof 47
Cancer|March 5, 2020
Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastomaHamed Akbari, Saima Rathore, Spyridon Bakas, et al.
Journal of Medical Internet Research|November 14, 2022
The Codevelopment of "My Kidneys & Me": A Digital Self-management Program for People With Chronic Kidney DiseaseCourtney J Lightfoot, Thomas J Wilkinson, Michelle Hadjiconstantinou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid TumorsManuel Hidalgo, Maria Martinez-Garcia, Christophe Le Tourneau, et al.
Human Mutation|July 11, 2012
Use of support vector machines for disease risk prediction in genome-wide association studies: concerns and opportunitiesFlorian Mittag, Finja Büchel, Mohamad Saad, et al.
Scientific Reports|August 24, 2022
In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastomaAinhoa Hernandez, Ana Maria Muñoz-Mármol, Anna Esteve-Codina, et al.
Archives of Neurology|February 11, 2009
Clinical and pathological continuum of multisystem TDP-43 proteinopathiesFelix Geser, Maria Martinez-Lage, John Robinson, et al.
Materials Science & Engineering. C, Materials for Biological Applications|March 4, 2017
Collagen-based silver nanoparticles: Study on cell viability, skin permeation, and swelling inhibitionVinicius Saura Cardoso, Marcelo de Carvalho Filgueiras, Yago Medeiros Dutra, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2023
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life settingAlba Rocabert, Beatriz Borjabad, Leire Berrocal, et al.
Journal of the National Cancer Institute|August 18, 2016
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled TrialPatricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2014
Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutationsLisa Zimmer, Fabrice Barlesi, Maria Martinez-Garcia, et al.
Pageof 47